SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
+0.87%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$213M
AUM Growth
+$213M
Cap. Flow
+$38.9M
Cap. Flow %
18.3%
Top 10 Hldgs %
45.19%
Holding
183
New
52
Increased
11
Reduced
18
Closed
46

Sector Composition

1 Healthcare 87.73%
2 Energy 1.29%
3 Communication Services 0%
4 Materials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PCYC
101
DELISTED
PHARMACYCLICS INC
PCYC
-2,860
Closed -$303K
KYTH
102
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
-66,200
Closed -$2.47M
ALXA
103
DELISTED
ALEXZA PHARMACEUTICALS INC COM STK NEW (DE)
ALXA
0
SQNM
104
DELISTED
SEQUENOM INC NEW
SQNM
-20,500
Closed -$48K
SGYPW
105
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
-349,217
Closed -$751K
ARIA
106
DELISTED
Ariad Pharmaceuticals Inc
ARIA
0
CASC
107
DELISTED
Cascadian Therapeutics, Inc.
CASC
-718,000
Closed -$1.26M
ECYT
108
DELISTED
Endocyte, Inc. Common Stock
ECYT
-55,849
Closed -$597K
WCG
109
DELISTED
Wellcare Health Plans, Inc.
WCG
0
ACHN
110
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
-453,380
Closed -$1.51M
STML
111
DELISTED
Stemline Therapeutics, Inc.
STML
-68,100
Closed -$1.34M
ALXN
112
DELISTED
Alexion Pharmaceuticals Inc
ALXN
0
ADXS
113
DELISTED
Advaxis, Inc.
ADXS
0
HSTO
114
DELISTED
Histogen Inc. Common Stock
HSTO
-105,860
Closed -$683K
ATHX
115
DELISTED
Athersys, Inc. Common Stock
ATHX
0
TWTR
116
DELISTED
Twitter, Inc.
TWTR
-72,300
Closed -$4.6M
CLVS
117
DELISTED
Clovis Oncology, Inc.
CLVS
0
SRNE
118
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-222,026
Closed -$1.8M
ALBO
119
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
0
INFI
120
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-70,000
Closed -$967K
PRTK
121
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-281,330
Closed -$945K
SGEN
122
DELISTED
Seagen Inc. Common Stock
SGEN
0
MRTX
123
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-12,213
Closed -$203K
LUMO
124
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
0
EYPT icon
125
EyePoint Pharmaceuticals
EYPT
$827M
0